miR-505-3p controls chemokine receptor up-regulation in macrophages: role in familial hypercholesterolemia

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
Rafael EscateLina Badimon

Abstract

Familial hypercholesterolemia (FH) conveys a high risk of premature atherosclerosis as a result of lifelong exposure to high LDL cholesterol levels that are not fully reduced by standard-of-care lipid-lowering treatment. Inflammatory mediators have played a role in the progression of atherosclerotic lesions. Here, we investigated whether innate immunity cells in patients with FH have a specific proinflammatory phenotype that is distinct from that of cells in normal participants. To this end, miR-505-3p-a microRNA related to chronic inflammation-and its target genes were investigated in monocyte-derived macrophages (MACs) of patients with FH (FH-MACs) and non-FH controls (co-MACs). On the basis of the profiler PCR array analysis of agomiR-505-3p-transfected MACs, we identified the chemokine receptors, CCR3, CCR4, and CXCR1, as genes that are regulated by miR-505-3p via the transcription factor, RUNX1. miR-505-3p was significantly down-regulated, whereas CCR3, CCR4, CXCR, and RUNX1 were increased in FH-MAC compared with co-MAC, with the increase being more evident in the proinflammatory M1-like FH-MAC. Chemokine receptor levels were unrelated to LDL plasma levels at entry, but correlated with age in patients with FH, not in contr...Continue Reading

References

Feb 1, 1988·The Journal of Experimental Medicine·S B Clarkson, P A Ory
Jun 10, 2000·Arteriosclerosis, Thrombosis, and Vascular Biology·V Llorente-CortésL Badimon
Mar 9, 2002·Arteriosclerosis, Thrombosis, and Vascular Biology·Vicenta Llorente-CortésLina Badimon
Sep 1, 1955·The Journal of Clinical Investigation·R J HAVELJ H BRAGDON
Apr 22, 2005·The New England Journal of Medicine·Göran K Hansson
Nov 11, 2005·Clinica Chimica Acta; International Journal of Clinical Chemistry·Mariame El MessalM John Chapman
Aug 22, 2006·Current Molecular Medicine·L BadimonT Padró
Sep 22, 2007·Annual Review of Pharmacology and Toxicology·Antonella Viola, Andrew D Luster
Aug 30, 2008·BMJ : British Medical Journal·Anthony S WierzbickiUNKNOWN Guideline Development Group
Nov 11, 2008·The New England Journal of Medicine·Paul M RidkerUNKNOWN JUPITER Study Group
Sep 3, 2010·Inflammatory Bowel Diseases·Feng WuJohn H Kwon
May 18, 2011·Cell Host & Microbe·Mihai G NeteaJos W M van der Meer
Jun 3, 2011·The Journal of Clinical Investigation·Christian WeberAlma Zernecke
Jun 17, 2011·Arteriosclerosis, Thrombosis, and Vascular Biology·Klaus LeyCatherine C Hedrick
Mar 1, 2012·Current Pharmaceutical Design·Alexios S AntonopoulosCharalambos Antoniades
Aug 8, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sandeep K RaghuwanshiRicardo M Richardson
Jan 18, 2013·Arteriosclerosis, Thrombosis, and Vascular Biology·Gang Liu, Edward Abraham
Feb 5, 2013·The Journal of Clinical Investigation·Anthony RousselleJohan Duchene
May 30, 2013·World Journal of Gastroenterology : WJG·Jennifer RaischHang Thi Thu Nguyen
Oct 4, 2014·Journal of the American College of Cardiology·Diederik F van WijkErik S G Stroes
Jan 23, 2015·Critical Care : the Official Journal of the Critical Care Forum·Siroon BekkeringNiels P Riksen
Feb 12, 2015·The Application of Clinical Genetics·Anja Vogt
Mar 17, 2015·Trends in Molecular Medicine·Ioannis AndreouMark W Feinberg
May 24, 2015·Cellular and Molecular Life Sciences : CMLS·Petra HartmannChristian Weber
Jul 15, 2015·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Yang YangGuofu Zhu
Aug 28, 2016·European Heart Journal·Alberico L CatapanoUNKNOWN ESC Scientific Document Group

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.